Management of Brucella endocarditis on native mitral valve in a patient with prosthetic aortic valve: a case report.
Katircibaşi
M Tuna
MT
Koçum
H Tolga
HT
Cölkesen
A Yücel
AY
Tekin
Abdullah
A
Sezgin
Alpay Turan
AT
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D001021:Aortic Valve; D002006:Brucellosis / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D002443:Ceftriaxone / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery / Q000628:therapy*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000382:microbiology*; D012293:Rifampin / Q000627:therapeutic use; D015047:Zoonoses
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002443:Ceftriaxone; D004318:Doxycycline; D012293:Rifampin